What is this medicine used for?
FDA-approved uses
- Insomnia with sleep-onset and sleep-maintenance benefit — Adults. Pediatric safety and efficacy are not established.Lunesta oral tablets.
What should I expect?
The medicine is intended to improve sleep on the nights it is taken. Next-day coordination and alertness can still be impaired, including when you feel that you slept well.
If sleep does not improve within 7–10 days or worsens, contact the prescriber rather than increasing the dose. Ongoing treatment should be reviewed for both sleep benefit and daytime safety.
How do I take it safely?
Take immediately before bed with 7–8 hours available. Avoid taking it with or immediately after a heavy, high-fat meal. Do not stay up doing activities afterward, repeat the dose or add another sleep medicine.
Older or frail adults, severe liver impairment and some potent interacting medicines have a lower maximum dose. Kidney impairment does not require the same adjustment. Follow the prescribed dose.
Avoid alcohol and unreviewed sedatives, including opioids. Have antifungals, antibiotics, seizure medicines and other interacting treatments checked. People taking 3 mg are cautioned against driving or hazardous activities the next day.
Do not use after prior Lunesta-related complex sleep behavior or allergy. Discuss breathing disease, liver disease, depression, suicidal thinking, falls and substance-use history.
Stop and contact the prescriber immediately if sleepwalking, sleep-driving or other behavior while not fully awake occurs. Unusual thinking, hallucinationsHallucinationsA hallucination is a sensory experience without a corresponding external source—for example, hearing a voice when nobody is speaking. It can involve hearing, sight, touch, smell or taste and may feel very real.A hallucination is an experience; a delusion is a belief. Hallucinations can have different causes, so an assessment is needed to understand them. or worsening mood also need prompt assessment.
Skip a missed dose if 7–8 hours are no longer available; never double or take a daytime catch-up dose. Regular use may need an individual stopping plan to limit withdrawal. Store securely and never share.
Discuss pregnancy or breastfeeding because available human data are limited. Pediatric use is not established.
What side effects should I know about?
- Unpleasant taste, headache, sleepiness, dizziness and dry mouth.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)Lunesta: current prescribing information
Which warning signs need help?
- FDA boxed warningFDA boxed warningAn FDA boxed warning is a prominently displayed warning in US prescribing information about especially serious risks, which may include death or serious injury. It is sometimes called a black-box warning.It highlights information that needs particular attention when deciding whether and how to use a medicine. A boxed warning does not mean the medicine is banned or that everyone will experience the harm. Read the medicine-specific warning and discuss it with your prescriber.: complex sleep behaviors, including sleepwalking, sleep-driving and other activities while not fully awake, can cause serious injury or death. They can occur after the first or a later dose, even at recommended doses and without alcohol. Stop the medicine immediately and contact the prescriber if this occurs.
- New suicidal thoughts or a severe mood or behavior change needs immediate clinical contact; get emergency help if someone cannot stay safe.
- Report severe confusion, hallucinationsHallucinationsA hallucination is a sensory experience without a corresponding external source—for example, hearing a voice when nobody is speaking. It can involve hearing, sight, touch, smell or taste and may feel very real.A hallucination is an experience; a delusion is a belief. Hallucinations can have different causes, so an assessment is needed to understand them. or unusual behavior promptly. Next-day impairment may occur even when you feel awake; do not drive when impaired.
- Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.
What else should I know to stay safe?
- Do not use after Lunesta-related complex sleep behavior or allergy. Review breathing disease, liver disease, depression, falls and substance-use history. Older or frail adults, severe liver impairment and certain potent interacting medicines require a lower maximum dose.
- Avoid alcohol and unreviewed sedatives, opioids or other sleep medicines. Have enzyme-blocking or enzyme-inducing medicines checked. The 3-mg dose carries a specific next-day driving caution; regular use may need an individual gradual stopping plan. Store securely and never share.
- Discuss pregnancy and breastfeeding because human evidence is limited. Pediatric safety and effectiveness are not established.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- An unpleasant taste is a recognized effect of eszopiclone; mention it if it makes treatment difficult.
- The 3-mg dose carries a specific next-day driving caution. More sleep benefit can come with a meaningful alertness trade-off.
- Being chemically different from benzodiazepines does not remove misuse, dependence or withdrawal risks.
How does it work?
Eszopiclone’s sleep-promoting effect is thought to involve GABA, a chemical messenger that helps restrain nerve-cell activity. It acts at receiving structures associated with this messenger, although the precise steps that produce sleep are not fully understood. Its effects can include both sleepiness and reduced alertness after waking.
Explore more in Brain & Science: Benzodiazepines and GABA: Alprazolam.
How was this medicine developed?
Lunesta received FDA approval in 2004, with studies examining sleep onset and maintenance. Subsequent safety labeling emphasized next-day impairment and complex sleep behaviors that can cause serious injury.
How do I say the name?
Eszopiclone: es-ZOE-pi-clone. Capital letters show the stressed syllable.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Lunesta: current prescribing information
- Lunesta: FDA approval history
- Eszopiclone: patient medicine information
- Lunesta: Package Insert / Prescribing Information / MOA
- Lunesta: FDA prescribing information
- Ambien: current prescribing information
- Eszopiclone: verified neutral parent, PubChem CID 969472
- ISMP List of Confused Drug Names
- Frequently Asked Questions about Labeling for Prescription Medicines | FDA
- Schizophrenia
- NIMH: Understanding psychosis
Giving medicine safely to children: family guide (PDF, 3 pages)

